Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 7323465 was granted and assigned to Actelion Pharmaceuticals Ltd on January, 2008 by the United States Patent and Trademark Office. | 7323465 | January 29, 2008 | |||||||
Patent 7435828 was granted and assigned to Actelion Pharmaceuticals Ltd on October, 2008 by the United States Patent and Trademark Office. | 7435828 | October 14, 2008 | |||||||
Patent 7094781 was granted and assigned to Actelion Pharmaceuticals Ltd on August, 2006 by the United States Patent and Trademark Office. | 7094781 | August 22, 2006 | |||||||
Patent 7192950 was granted and assigned to Actelion Pharmaceuticals Ltd on March, 2007 by the United States Patent and Trademark Office. | 7192950 | March 20, 2007 | |||||||
Patent 7375227 was granted and assigned to Actelion Pharmaceuticals Ltd on May, 2008 by the United States Patent and Trademark Office. | 7375227 | May 20, 2008 | |||||||
Patent 7435815 was granted and assigned to Actelion Pharmaceuticals Ltd on October, 2008 by the United States Patent and Trademark Office. | 7435815 | October 14, 2008 | |||||||
Patent 7279578 was granted and assigned to Actelion Pharmaceuticals Ltd on October, 2007 by the United States Patent and Trademark Office. | 7279578 | October 9, 2007 | |||||||
Patent 7091201 was granted and assigned to Actelion Pharmaceuticals Ltd on August, 2006 by the United States Patent and Trademark Office. | 7091201 | August 15, 2006 | |||||||
Patent 12121516 was granted and assigned to Actelion Pharmaceuticals Ltd on October, 2024 by the United States Patent and Trademark Office. | 12121516 | October 22, 2024 |